[The biochemical mechanisms of drug resistance to N-alkyl-N-nitrosoureas and derivatives of cis-dichlorodiammineplatinum].
D000818:Animals; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002945:Cisplatin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism; D007941:Leukemia P388 / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D015376:Nimustine / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009944:Organoplatinum Compounds; D015376:Nimustine; C055928:cycloplatam; D002945:Cisplatin
Biokhimicheskie mekhanizmy lekarstvennoĭ ustoĭchivosti k N-alkil-N-nitrozomochevinam i proizvodnym tsis-dikhlordiaminoplatiny.